Liquid Biopsy of Methylation Biomarkers in Cell-Free DNA

Bray, 2018, Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J. Clin., 68, 394, 10.3322/caac.21492 Wan, 2017, Liquid biopsies come of age: towards implementation of circulating tumour DNA, Nat. Rev. Cancer, 17, 223, 10.1038/nrc.2017.7 Avgerinos, 2019, Obesity and cancer risk: emerging biological mechanisms and perspectives, Metabolism, 92, 121, 10.1016/j.metabol.2018.11.001 Diaz, 2014, Liquid biopsies: genotyping circulating tumor DNA, J. Clin. Oncol., 32, 579, 10.1200/JCO.2012.45.2011 Schwarzenbach, 2011, Cell-free nucleic acids as biomarkers in cancer patients, Nat. Rev. Cancer, 11, 426, 10.1038/nrc3066 van der Pol, 2019, Toward the early detection of cancer by decoding the epigenetic and environmental fingerprints of cell-free DNA, Cancer Cell, 36, 350, 10.1016/j.ccell.2019.09.003 Jones, 2012, Functions of DNA methylation: islands, start sites, gene bodies and beyond, Nat. Rev. Genet., 13, 484, 10.1038/nrg3230 Esteller, 2008, Epigenetics in cancer, N. Engl. J. Med., 358, 1148, 10.1056/NEJMra072067 Baylin, 2011, A decade of exploring the cancer epigenome - biological and translational implications, Nat. Rev. Cancer, 11, 726, 10.1038/nrc3130 Dor, 2018, Principles of DNA methylation and their implications for biology and medicine, Lancet, 392, 777, 10.1016/S0140-6736(18)31268-6 Smith, 2013, DNA methylation: roles in mammalian development, Nat. Rev. Genet., 14, 204, 10.1038/nrg3354 Moss, 2018, Comprehensive human cell-type methylation atlas reveals origins of circulating cell-free DNA in health and disease, Nat. Commun., 9, 5068, 10.1038/s41467-018-07466-6 Feng, 2019, Disease prediction by cell-free DNA methylation, Brief. Bioinform., 20, 585, 10.1093/bib/bby029 Kanwal, 2015, Cancer epigenetics: an introduction, Methods Mol. Biol., 1238, 3, 10.1007/978-1-4939-1804-1_1 Laird, 2003, The power and the promise of DNA methylation markers, Nat. Rev. Cancer, 3, 253, 10.1038/nrc1045 Hursting, 2010, Energy balance, host-related factors, and cancer progression, J. Clin. Oncol., 28, 4058, 10.1200/JCO.2010.27.9935 Rabin-Court, 2019, Obesity-associated, but not obesity-independent, tumors respond to insulin by increasing mitochondrial glucose oxidation, PLoS One, 14, 10.1371/journal.pone.0218126 Moran, 2016, Epigenetic profiling to classify cancer of unknown primary: a multicentre, retrospective analysis, Lancet Oncol., 17, 1386, 10.1016/S1470-2045(16)30297-2 FDA, 2018 Thierry, 2016, Origins, structures, and functions of circulating DNA in oncology, Cancer Metastasis Rev., 35, 347, 10.1007/s10555-016-9629-x Lo, 2010, Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus, Sci. Transl. Med., 2, 10.1126/scitranslmed.3001720 Giacona, 1998, Cell-free DNA in human blood plasma: length measurements in patients with pancreatic cancer and healthy controls, Pancreas, 17, 89, 10.1097/00006676-199807000-00012 Warton, 2014, Methylation-capture and next-generation sequencing of free circulating DNA from human plasma, BMC Genomics, 15, 476, 10.1186/1471-2164-15-476 Diehl, 2008, Circulating mutant DNA to assess tumor dynamics, Nat. Med., 14, 985, 10.1038/nm.1789 Jahr, 2001, DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells, Cancer Res., 61, 1659 Fleischhacker, 2007, Circulating nucleic acids (CNAs) and cancer--a survey, Biochim. Biophys. Acta, 1775, 181 Bettegowda, 2014, Detection of circulating tumor DNA in early- and late-stage human malignancies, Sci. Transl. Med., 6, 10.1126/scitranslmed.3007094 Butler, 2017, Circulating-tumor DNA as an early detection and diagnostic tool, Curr. Opin. Genet. Dev., 42, 14, 10.1016/j.gde.2016.12.003 Petit, 2019, Cell-free DNA as a diagnostic blood-based biomarker for colorectal cancer: a systematic review, J. Surg. Res., 236, 184, 10.1016/j.jss.2018.11.029 Frommer, 1992, A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands, Proc. Natl. Acad. Sci. U. S. A., 89, 1827, 10.1073/pnas.89.5.1827 Beck, 2008, The methylome: approaches for global DNA methylation profiling, Trends Genet., 24, 231, 10.1016/j.tig.2008.01.006 Gu, 2011, Preparation of reduced representation bisulfite sequencing libraries for genome-scale DNA methylation profiling, Nat. Protoc., 6, 468, 10.1038/nprot.2010.190 Wen, 2015, Genome-scale detection of hypermethylated CpG islands in circulating cell-free DNA of hepatocellular carcinoma patients, Cell Res., 25, 1250, 10.1038/cr.2015.126 Huang, 2019, Cell-free DNA methylation profiling analysis-technologies and bioinformatics, Cancers (Basel), 11, 1741, 10.3390/cancers11111741 Lissa, 2016, Methylation analyses in liquid biopsy, Transl. Lung Cancer Res., 5, 492, 10.21037/tlcr.2016.10.03 Meissner, 2008, Genome-scale DNA methylation maps of pluripotent and differentiated cells, Nature, 454, 766, 10.1038/nature07107 Estival, 2019, Pyrosequencing versus methylation-specific PCR for assessment of MGMT methylation in tumor and blood samples of glioblastoma patients, Sci. Rep., 9, 10.1038/s41598-019-47642-2 Huang, 2014, Evaluation of INK4A promoter methylation using pyrosequencing and circulating cell-free DNA from patients with hepatocellular carcinoma, Clin. Chem. Lab. Med., 52, 899, 10.1515/cclm-2013-0885 Kristensen, 2016, Aberrant methylation of cell-free circulating DNA in plasma predicts poor outcome in diffuse large B cell lymphoma, Clin. Epigenetics, 8, 95, 10.1186/s13148-016-0261-y Bibikova, 2011, High density DNA methylation array with single CpG site resolution, Genomics, 98, 288, 10.1016/j.ygeno.2011.07.007 Moran, 2016, Validation of a DNA methylation microarray for 850,000 CpG sites of the human genome enriched in enhancer sequences, Epigenomics, 8, 389, 10.2217/epi.15.114 Farlik, 2015, Single-cell DNA methylome sequencing and bioinformatic inference of epigenomic cell-state dynamics, Cell Rep., 10, 1386, 10.1016/j.celrep.2015.02.001 Guo, 2015, Profiling DNA methylome landscapes of mammalian cells with single-cell reduced-representation bisulfite sequencing, Nat. Protoc., 10, 645, 10.1038/nprot.2015.039 Samorodnitsky, 2015, Comparison of custom capture for targeted next-generation DNA sequencing, J. Mol. Diagn., 17, 64, 10.1016/j.jmoldx.2014.09.009 Liu, 2018, Targeted methylation sequencing of plasma cell-free DNA for cancer detection and classification, Ann. Oncol., 29, 1445, 10.1093/annonc/mdy119 Diep, 2012, Library-free methylation sequencing with bisulfite padlock probes, Nat. Methods, 9, 270, 10.1038/nmeth.1871 Deng, 2009, Targeted bisulfite sequencing reveals changes in DNA methylation associated with nuclear reprogramming, Nat. Biotechnol., 27, 353, 10.1038/nbt.1530 Weber, 2005, Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells, Nat. Genet., 37, 853, 10.1038/ng1598 Shen, 2018, Sensitive tumour detection and classification using plasma cell-free DNA methylomes, Nature, 563, 579, 10.1038/s41586-018-0703-0 Aberg, 2017, A MBD-seq protocol for large-scale methylome-wide studies with (very) low amounts of DNA, Epigenetics, 12, 743, 10.1080/15592294.2017.1335849 Song, 2011, Selective chemical labeling reveals the genome-wide distribution of 5-hydroxymethylcytosine, Nat. Biotechnol., 29, 68, 10.1038/nbt.1732 Han, 2016, A highly sensitive and robust method for genome-wide 5hmC profiling of rare cell populations, Mol. Cell, 63, 711, 10.1016/j.molcel.2016.06.028 Chan, 2017, Enrichment methods provide a feasible approach to comprehensive and adequately powered investigations of the brain methylome, Nucleic Acids Res., 45, 10.1093/nar/gkx143 Fouse, 2010, Genome-scale DNA methylation analysis, Epigenomics, 2, 105, 10.2217/epi.09.35 Khulan, 2006, Comparative isoschizomer profiling of cytosine methylation: the HELP assay, Genome Res., 16, 1046, 10.1101/gr.5273806 Heitzer, 2019, Current and future perspectives of liquid biopsies in genomics-driven oncology, Nat. Rev. Genet., 20, 71, 10.1038/s41576-018-0071-5 Wu, 2016, GMAP and GSNAP for genomic sequence alignment: enhancements to speed, accuracy, and functionality, Methods Mol. Biol., 1418, 283, 10.1007/978-1-4939-3578-9_15 Krueger, 2011, Bismark: a flexible aligner and methylation caller for bisulfite-seq applications, Bioinformatics, 27, 1571, 10.1093/bioinformatics/btr167 Daca-Roszak, 2015, Impact of SNPs on methylation readouts by Illumina Infinium HumanMethylation450 BeadChip Array: implications for comparative population studies, BMC Genomics, 16, 1003, 10.1186/s12864-015-2202-0 Lienhard, 2017, QSEA—modelling of genome-wide DNA methylation from sequencing enrichment experiments, Nucleic Acids Res., 45, 10.1093/nar/gkw1193 van den Oord, 2013, Estimation of CpG coverage in whole methylome next-generation sequencing studies, BMC Bioinforma., 14, 50, 10.1186/1471-2105-14-50 Hansen, 2012, BSmooth: from whole genome bisulfite sequencing reads to differentially methylated regions, Genome Biol., 13, R83, 10.1186/gb-2012-13-10-r83 Smyth, 2004, Linear models and empirical Bayes methods for assessing differential expression in microarray experiments, Stat. Appl. Genet. Mol. Biol., 3, 1, 10.2202/1544-6115.1027 Aryee, 2014, Minfi: a flexible and comprehensive bioconductor package for the analysis of Infinium DNA methylation microarrays, Bioinformatics, 30, 1363, 10.1093/bioinformatics/btu049 Zhao, 2019, CrossICC: iterative consensus clustering of cross-platform gene expression data without adjusting batch effect, Brief. Bioinform., 21, 1818, 10.1093/bib/bbz116 Akalin, 2012, methylKit: a comprehensive R package for the analysis of genome-wide DNA methylation profiles, Genome Biol, 13, 10.1186/gb-2012-13-10-r87 Feng, 2014, A Bayesian hierarchical model to detect differentially methylated loci from single nucleotide resolution sequencing data, Nucleic Acids Res., 42, 10.1093/nar/gku154 Wreczycka, 2017, Strategies for analyzing bisulfite sequencing data, J. Biotechnol., 261, 105, 10.1016/j.jbiotec.2017.08.007 Rakyan, 2011, Epigenome-wide association studies for common human diseases, Nat. Rev. Genet., 12, 529, 10.1038/nrg3000 Guo, 2017, Identification of methylation haplotype blocks aids in deconvolution of heterogeneous tissue samples and tumor tissue-of-origin mapping from plasma DNA, Nat. Genet., 49, 635, 10.1038/ng.3805 Akalin, 2015, Genomation: a toolkit to summarize, annotate and visualize genomic intervals, Bioinformatics, 31, 1127, 10.1093/bioinformatics/btu775 Zhu, 2010, ChIPpeakAnno: a bioconductor package to annotate ChIP-seq and ChIP-chip data, BMC Bioinforma., 11, 237, 10.1186/1471-2105-11-237 Vrba, 2018, A suite of DNA methylation markers that can detect most common human cancers, Epigenetics, 13, 61, 10.1080/15592294.2017.1412907 Teschendorff, 2017, A comparison of reference-based algorithms for correcting cell-type heterogeneity in epigenome-wide association studies, BMC Bioinforma., 18, 105, 10.1186/s12859-017-1511-5 Kang, 2017, CancerLocator: non-invasive cancer diagnosis and tissue-of-origin prediction using methylation profiles of cell-free DNA, Genome Biol., 18, 53, 10.1186/s13059-017-1191-5 Li, 2018, CancerDetector: ultrasensitive and non-invasive cancer detection at the resolution of individual reads using cell-free DNA methylation sequencing data, Nucleic Acids Res., 46, 10.1093/nar/gky423 Church, 2014, Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer, Gut, 63, 317, 10.1136/gutjnl-2012-304149 Nian, 2017, Diagnostic accuracy of methylated SEPT9 for blood-based colorectal cancer detection: a systematic review and meta-analysis, Clin. Transl. Gastroenterol., 8, 10.1038/ctg.2016.66 Luo, 2020, Circulating tumor DNA methylation profiles enable early diagnosis, prognosis prediction, and screening for colorectal cancer, Sci. Transl. Med., 12, 10.1126/scitranslmed.aax7533 Pedersen, 2015, Evaluation of an assay for methylated BCAT1 and IKZF1 in plasma for detection of colorectal neoplasia, BMC Cancer, 15, 654, 10.1186/s12885-015-1674-2 Xu, 2017, Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma, Nat. Mater., 16, 1155, 10.1038/nmat4997 Liu, 2020, Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA, Ann. Oncol., 31, 745, 10.1016/j.annonc.2020.02.011 Taylor, 2020, Comment on 'Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA' by M. C. Liu et al, Ann. Oncol., 31, 1266, 10.1016/j.annonc.2020.04.013 Song, 2017, 5-Hydroxymethylcytosine signatures in cell-free DNA provide information about tumor types and stages, Cell Res., 27, 1231, 10.1038/cr.2017.106 Li, 2017, 5-Hydroxymethylcytosine signatures in circulating cell-free DNA as diagnostic biomarkers for human cancers, Cell Res., 27, 1243, 10.1038/cr.2017.121 Cai, 2019, Genome-wide mapping of 5-hydroxymethylcytosines in circulating cell-free DNA as a non-invasive approach for early detection of hepatocellular carcinoma, Gut, 68, 2195, 10.1136/gutjnl-2019-318882 Taieb, 2019, Analysis of circulating tumour DNA (ctDNA) from patients enrolled in the IDEA-FRANCE phase III trial: prognostic and predictive value for adjuvant treatment duration, Ann. Oncol., 30, v867, 10.1093/annonc/mdz394.019 Takahashi, 2017, Correlation of methylated circulating tumor DNA with response to neoadjuvant chemotherapy in breast cancer patients, Clin. Breast Cancer, 17, 61, 10.1016/j.clbc.2016.06.006 Abbosh, 2017, Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution, Nature, 545, 446, 10.1038/nature22364 Chaudhuri, 2017, Early detection of molecular residual disease in localized lung cancer by circulating tumor DNA profiling, Cancer Discov., 7, 1394, 10.1158/2159-8290.CD-17-0716 Garcia-Murillas, 2015, Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer, Sci. Transl. Med., 7, 10.1126/scitranslmed.aab0021 Tie, 2016, Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer, Sci. Transl. Med., 8, 10.1126/scitranslmed.aaf6219 Tuaeva, 2019, Translational application of circulating DNA in oncology: review of the last decades achievements, Cells, 8, 1251, 10.3390/cells8101251 Khier, 2018, Kinetics of circulating cell-free DNA for biomedical applications: critical appraisal of the literature, Future Sci. OA, 4, 10.4155/fsoa-2017-0140 Di Meo, 2017, Liquid biopsy: a step forward towards precision medicine in urologic malignancies, Mol. Cancer, 16, 80, 10.1186/s12943-017-0644-5 Yao, 2016, Evaluation and comparison of in vitro degradation kinetics of DNA in serum, urine and saliva: a qualitative study, Gene, 590, 142, 10.1016/j.gene.2016.06.033 Barault, 2015, Digital PCR quantification of MGMT methylation refines prediction of clinical benefit from alkylating agents in glioblastoma and metastatic colorectal cancer, Ann. Oncol., 26, 1994, 10.1093/annonc/mdv272 Visvanathan, 2017, Monitoring of serum DNA methylation as an early independent marker of response and survival in metastatic breast cancer: TBCRC 005 prospective biomarker study, J. Clin. Oncol., 35, 751, 10.1200/JCO.2015.66.2080 Riethdorf, 2017, The current status and clinical value of circulating tumor cells and circulating cell-free tumor DNA in bladder cancer, Transl. Androl. Urol., 6, 1090, 10.21037/tau.2017.09.16 Locke, 2019, DNA methylation cancer biomarkers: translation to the clinic, Front Genet, 10, 1150, 10.3389/fgene.2019.01150 Sun, 2015, Plasma DNA tissue mapping by genome-wide methylation sequencing for noninvasive prenatal, cancer, and transplantation assessments, Proc. Natl. Acad. Sci. U. S. A., 112, E5503, 10.1073/pnas.1508736112 Lehmann-Werman, 2016, Identification of tissue-specific cell death using methylation patterns of circulating DNA, Proc. Natl. Acad. Sci. U. S. A., 113, E1826, 10.1073/pnas.1519286113 Gai, 2018, Liver- and colon-specific DNA methylation markers in plasma for investigation of colorectal cancers with or without liver metastases, Clin. Chem., 64, 1239, 10.1373/clinchem.2018.290304 Elazezy, 2018, Techniques of using circulating tumor DNA as a liquid biopsy component in cancer management, Comput. Struct. Biotechnol. J., 16, 370, 10.1016/j.csbj.2018.10.002 Klutstein, 2016, DNA methylation in cancer and aging, Cancer Res., 76, 3446, 10.1158/0008-5472.CAN-15-3278 Yang, 2019, Genetic data from nearly 63,000 women of European descent predicts DNA methylation biomarkers and epithelial ovarian cancer risk, Cancer Res., 79, 505, 10.1158/0008-5472.CAN-18-2726 Breitbach, 1985, et al. (2014) Direct measurement of cell-free DNA from serially collected capillary plasma during incremental exercise, J. Appl. Physiol., 117, 119, 10.1152/japplphysiol.00002.2014 Glezeva, 2019, Targeted DNA methylation profiling of human cardiac tissue reveals novel epigenetic traits and gene deregulation across different heart failure patient subtypes, Circ. Heart Fail., 12, 10.1161/CIRCHEARTFAILURE.118.005765 Worm Orntoft, 2017, Comparative analysis of 12 different kits for bisulfite conversion of circulating cell-free DNA, Epigenetics, 12, 626, 10.1080/15592294.2017.1334024 Gold, 2015, Do circulating tumor cells, exosomes, and circulating tumor nucleic acids have clinical utility? A report of the association for molecular pathology, J. Mol. Diagn., 17, 209, 10.1016/j.jmoldx.2015.02.001 Fornvik, 2019, Detection of circulating tumor cells and circulating tumor DNA before and after mammographic breast compression in a cohort of breast cancer patients scheduled for neoadjuvant treatment, Breast Cancer Res. Treat., 177, 447, 10.1007/s10549-019-05326-5 Merker, 2018, Circulating tumor DNA analysis in patients with cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review, J. Clin. Oncol., 36, 1631, 10.1200/JCO.2017.76.8671 Pantel, 2019, Liquid biopsy and minimal residual disease - latest advances and implications for cure, Nat. Rev. Clin. Oncol., 16, 409, 10.1038/s41571-019-0187-3 Tsang, 2017, Integrative single-cell and cell-free plasma RNA transcriptomics elucidates placental cellular dynamics, Proc. Natl. Acad. Sci. U. S. A., 114, E7786, 10.1073/pnas.1710470114 Sun, 2018, GeneCT: a generalizable cancerous status and tissue origin classifier for pan-cancer biopsies, Bioinformatics, 34, 4129, 10.1093/bioinformatics/bty524 Barault, 2018, Discovery of methylated circulating DNA biomarkers for comprehensive non-invasive monitoring of treatment response in metastatic colorectal cancer, Gut, 67, 1995, 10.1136/gutjnl-2016-313372 Boeckx, 2018, Mutation and methylation analysis of circulating tumor DNA can be used for follow-up of metastatic colorectal cancer patients, Clin. Colorectal Cancer, 17, e369, 10.1016/j.clcc.2018.02.006 Mouliere, 2018, Enhanced detection of circulating tumor DNA by fragment size analysis, Sci. Transl. Med., 10, 10.1126/scitranslmed.aat4921 Elias, 2017, Diagnostic potential for a serum miRNA neural network for detection of ovarian cancer, eLife, 6, 10.7554/eLife.28932 Schöb, 2006, The first high-resolution DNA "methylome", Cell, 126, 1025, 10.1016/j.cell.2006.09.002 Widschwendter, 2017, The potential of circulating tumor DNA methylation analysis for the early detection and management of ovarian cancer, Genome Med., 9, 116, 10.1186/s13073-017-0500-7 Meissner, 2005, Reduced representation bisulfite sequencing for comparative high-resolution DNA methylation analysis, Nucleic Acids Res., 33, 5868, 10.1093/nar/gki901 Li, 2019, Detection of colorectal cancer in circulating cell-free DNA by methylated CpG tandem amplification and sequencing, Clin. Chem., 65, 916, 10.1373/clinchem.2019.301804 Holmila, 2017, Targeted deep sequencing of plasma circulating cell-free DNA reveals Vimentin and Fibulin 1 as potential epigenetic biomarkers for hepatocellular carcinoma, PLoS One, 12, 10.1371/journal.pone.0174265 Gallardo-Gómez, 2018, A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples, Clin. Epigenetics, 10, 53, 10.1186/s13148-018-0487-y Yu, 2005, High throughput screening of methylation status of genes in prostate cancer using an oligonucleotide methylation array, Carcinogenesis, 26, 471, 10.1093/carcin/bgh310 Herman, 1996, Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands, Proc. Natl. Acad. Sci. U. S. A., 93, 9821, 10.1073/pnas.93.18.9821 Hauser, 2013, Serum DNA hypermethylation in patients with kidney cancer: results of a prospective study, Anticancer Res., 33, 4651 Oakes, 2006, Evaluation of a quantitative DNA methylation analysis technique using methylation-sensitive/dependent restriction enzymes and real-time PCR, Epigenetics, 1, 146, 10.4161/epi.1.3.3392 Oda, 2009, High-resolution genome-wide cytosine methylation profiling with simultaneous copy number analysis and optimization for limited cell numbers, Nucleic Acids Res., 37, 3829, 10.1093/nar/gkp260 Shen, 2019, Preparation of cfMeDIP-seq libraries for methylome profiling of plasma cell-free DNA, Nat. Protoc., 14, 2749, 10.1038/s41596-019-0202-2 Lasseter, 2020, Plasma cell-free DNA variant analysis compared with methylated DNA analysis in renal cell carcinoma, Genet Med., 22, 1366, 10.1038/s41436-020-0801-x Liang, 2019, Non-invasive diagnosis of early-stage lung cancer using high-throughput targeted DNA methylation sequencing of circulating tumor DNA (ctDNA), Theranostics, 9, 2056, 10.7150/thno.28119 Hulbert, 2017, Early detection of lung cancer using DNA promoter hypermethylation in plasma and sputum, Clin. Cancer Res., 23, 1998, 10.1158/1078-0432.CCR-16-1371 Guler, 2020, Detection of early stage pancreatic cancer using 5-hydroxymethylcytosine signatures in circulating cell free DNA, Nat. Commun., 11, 5270, 10.1038/s41467-020-18965-w